PlexBio Co., Ltd. (TPEX:6572)
Taiwan · Delayed Price · Currency is TWD 12.25
-0.75 (-5.77%)
Apr 20, 2026, 1:21 PM CST
PlexBio Revenue
In the year 2025, PlexBio had annual revenue of 127.10M TWD, down -0.76%. PlexBio had revenue of 58.28M in the half year ending June 30, 2025, a decrease of -39.81%.
Revenue
127.10M
Revenue Growth
-0.76%
P/S Ratio
10.60
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 127.10M | -967.00K | -0.76% |
| Dec 31, 2024 | 128.06M | -39.11M | -23.40% |
| Dec 31, 2023 | 167.18M | -24.01M | -12.56% |
| Dec 31, 2022 | 191.19M | 66.25M | 53.02% |
| Dec 31, 2021 | 124.94M | 23.60M | 23.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.80B |
| Cowealth Medical Holding | 2.96B |
| Wellell | 2.40B |
| OK Biotech | 1.56B |
| AViTA | 936.39M |
| Bioptik Technology Incorporation | 837.19M |
| Diamond Biotechnology | 698.11M |
| Radiant Innovation | 387.58M |